-James K Liao Researcher Activity Profile

Research Author Detailed Information 

James K Liao Publication Rate By Year

James K Liao has published 1 paper(s) in 2003, 2 paper(s) in 2004, 2 paper(s) in 2005, 2 paper(s) in 2006, 7 paper(s) in 2007, 15 paper(s) in 2008, for a total of 29 research publications in total.

James K Jk Liao Author Information

LAST NAME: liao

FIRST NAME: James K

INITIALS: jk

AFFILIATION:

Papers

James K Liao's Publication Record

1. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. Year Published: 2007
Vascular Medicine Research Unit, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02139, USA.
2. [Change of nuclear factor-kappaB activity in early burn injury and its significance] Year Published: 2003
Emergency Department, Guangdong Provincial Crops Hospital, Chinese People's Armed Police Forces, Guangzhou 510507, Guangdong, China.
3. Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease. Year Published: 2004
The Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Cambridge, MA 02139, USA.
4. Clinical implications for statin pleiotropy. Year Published: 2005
Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02139, USA. jliao@rics.bwh.harvard.edu
5. Rapid nongenomic actions of thyroid hormone. Year Published: 2006
Vascular Medicine Research, Brigham and Women's Hospital and Harvard Medical School, Cambridge, MA 02139, USA.
6. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Year Published: 2007
Vascular Medicine Research Unit, Brigham & Women's Hospital, Boston, MA, USA.
7. Safety and efficacy of statins in Asians. Year Published: 2007
Brigham and Women's Hospital, Cambridge, Massachusetts; Harvard Medical School, Cambridge, Massachusetts, USA. jliao@rics.bwh.harvard.edu
8. Rho kinase (ROCK) inhibitors. Year Published: 2007
The Vascular Medicine Research Unit, Brigham and Women's Hospital, Cambridge 02139 and Harvard Medical School, Boston, Massachusetts, USA. jliao@rics.bwh.harvard.edu
9. Distribution of sphingosine kinase activity and mRNA in rodent brain. Year Published: 2007
Stroke and Neurovascular Regulation Laboratory, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
10. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase? Year Published: 2007
Vascular Medicine Research, Brigham & Women's Hospital, 65 Landsdowne Street, Room 275, Cambridge, MA 02139, USA. jliao@rics.bwh.harvard.edu
11. Effect of ramipril on the incidence of diabetes. Year Published: 2008
12. Effect of rosiglitazone on the frequency of diabetes. Year Published: 2008
13. Primary prevention of cardiovascular disease with pravastatin. Year Published: 2008
14. Effect of ramipril on the incidence of diabetes. Year Published: 2008
15. Effect of rosiglitazone on the frequency of diabetes. Year Published: 2008
16. Primary prevention of cardiovascular disease with pravastatin. Year Published: 2008
17. Is statin discontinuation an option in patients who have had a stroke? Year Published: 2008
Vascular Medicine Research, Brigham and Women's Hospital, 65 Landsdowne Street, Room 275, Cambridge, MA 02139, USA. jliao@rics.bwh.harvard.edu
18. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. Year Published: 2005
Neuroprotection Research Laboratory, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, 02129, USA.
19. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. Year Published: 2007
Department of Radiology, Stroke and Neurovascular Regulation Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
20. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Year Published: 2008
Vascular Medicine Research Unit, Brigham and Women's Hospital and Harvard Medical School, Cambridge, MA 02139, USA.
21. Effect of ramipril on the incidence of diabetes. Year Published: 2008
22. Effect of rosiglitazone on the frequency of diabetes. Year Published: 2008
23. Primary prevention of cardiovascular disease with pravastatin. Year Published: 2008
24. Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease. Year Published: 2004
The Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Cambridge, MA 02139, USA.
25. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Year Published: 2008
Vascular Medicine Research Unit, Brigham and Women's Hospital and Harvard Medical School, Cambridge, MA 02139, USA.
26. Linking Notch signaling to ischemic stroke. Year Published: 2008
Department of Cell Biology, Harvard Medical School, Boston, MA 02115.
27. Linking Notch signaling to ischemic stroke. Year Published: 2008
Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
28. A method for measuring rho kinase activity in tissues and cells. Year Published: 2008
Vascular Medicine Research Unit, Brigham and Women's Hospital and Harvard, Medical School, Boston, Massachusetts.
29. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. Year Published: 2006
Vascular Medicine Research Unit, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.